Deze pagina is automatisch vertaald en de nauwkeurigheid van de vertaling kan niet worden gegarandeerd. Raadpleeg de Engelse versie voor een brontekst.

Video versus directe laryngoscopie voor tracheale intubatie bij pediatrische chirurgie (VIDEOKIDS)

17 september 2026 bijgewerkt door: Manuel Taboada Muñiz, Hospital Clinico Universitario de Santiago

Videolaryngoscopie versus directe laryngoscopie voor tracheale intubatie bij kinderchirurgie: De VIDEOKIDS pragmatische multicenter gerandomiseerde studie.

Tracheal intubation in paediatric patients is a high-risk procedure in which failure to achieve successful intubation on the first attempt is associated with an increased risk of complications, including hypoxaemia and airway trauma. Videolaryngoscopes have been increasingly adopted in clinical practice because they improve glottic visualisation; however, evidence of their benefit in paediatric patients remains inconsistent.

The VIDEOKIDS trial is a large, pragmatic, international, multicentre, randomised controlled trial designed to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing surgery under general anaesthesia. The primary objective is to determine whether videolaryngoscopy increases the rate of successful intubation on the first attempt compared with direct laryngoscopy.

Studie Overzicht

Gedetailleerde beschrijving

The purpose of this prospective, international, multicentre, randomised controlled trial is to compare videolaryngoscopy with direct laryngoscopy as the initial technique for tracheal intubation in paediatric patients undergoing elective surgery under general anaesthesia. We hypothesise that videolaryngoscopy will increase the frequency of successful intubation on the first attempt compared with direct laryngoscopy.

Eligible patients aged 0 to 16 years requiring orotracheal intubation will be randomly assigned in a 1:1 ratio to videolaryngoscopy or direct laryngoscopy for the first intubation attempt. The specific device and blade type, as well as all aspects of peri-intubation management, including patient positioning, preoxygenation, and pharmacological agents, will be determined by the attending anaesthesiologist according to local practice.

The primary outcome is successful tracheal intubation on the first attempt. Secondary outcomes include time to intubation, number of intubation attempts, glottic visualisation, need for adjunct airway devices, and intubation-related complications.

The primary analysis will follow the intention-to-treat principle. A mixed-effects logistic regression model will be used to account for centre-level variability and prespecified clinically relevant covariates.

Current evidence in paediatric populations remains inconclusive, with recent meta-analyses showing no clear improvement in first-attempt success despite better glottic visualisation with videolaryngoscopy.

The trial is expected to enrol approximately 5,600 patients across 15 to 25 hospitals in multiple countries, including Spain and Latin America. Recruitment is planned to begin in May 2026.

Studietype

Ingrijpend

Inschrijving (Geschat)

5562

Fase

  • Niet toepasbaar

Contacten en locaties

In dit gedeelte vindt u de contactgegevens van degenen die het onderzoek uitvoeren en informatie over waar dit onderzoek wordt uitgevoerd.

Studiecontact

  • Naam: Manuel Taboada Muñiz, Ph.D.
  • Telefoonnummer: +34678195618
  • E-mail: manutabo@yahoo.es

Studie Locaties

    • A CORUÑA
      • Santiago de Compostela, A CORUÑA, Spanje, 15706
        • Werving
        • Hospital Clínico Universitario de Santiago de Compostela
        • Contact:
          • Manuel Taboada Muñiz, Ph.D.
          • Telefoonnummer: 0034 981950674
          • E-mail: manutabo@yahoo.es
        • Contact:

Deelname Criteria

Onderzoekers zoeken naar mensen die aan een bepaalde beschrijving voldoen, de zogenaamde geschiktheidscriteria. Enkele voorbeelden van deze criteria zijn iemands algemene gezondheidstoestand of eerdere behandelingen.

Geschiktheidscriteria

Leeftijden die in aanmerking komen voor studie

1 seconde tot 16 uur (Kind)

Accepteert gezonde vrijwilligers

Nee

Geslachten die in aanmerking komen voor studie

Allemaal

Beschrijving

Inclusion Criteria:

  • Paediatric patients (age 0-16 years),
  • Undergoing elective or scheduled surgery under general anaesthesia requiring orotracheal intubation,
  • Planned tracheal intubation using either videolaryngoscopy or direct laryngoscopy as the initial technique,
  • Informed or general consent given, according to the relevant ethics committee statement,.

Exclusion Criteria:

  • Known upper airway anatomical abnormalities or clinical conditions requiring a specific intubation technique (e.g., fibreoptic intubation),
  • Requirement for emergent tracheal intubation that does not allow adequate randomisation,
  • Refusal of parents or legal guardians to participate in the study.

Studie plan

Dit gedeelte bevat details van het studieplan, inclusief hoe de studie is opgezet en wat de studie meet.

Hoe is de studie opgezet?

Ontwerpdetails

  • Primair doel: Ondersteunende zorg
  • Toewijzing: Gerandomiseerd
  • Interventioneel model: Parallelle opdracht
  • Masker: Enkel

Wapens en interventies

Deelnemersgroep / Arm
Interventie / Behandeling
Actieve vergelijker: Videolaryngoscope group

For patients assigned to the videolaryngoscope Group, the operator will use a video laryngoscope on the first laryngoscopy attempt.

For patients assigned to the videolaryngoscope Group, the operator will use a video laryngoscope on the first laryngoscopy attempt.

Actieve vergelijker: Direct laryngoscope group

For patients assigned to the laryngoscope Group, the operator will use a Macintosh laryngoscope on the first laryngoscopy attempt.

For patients assigned to the laryngoscope Group, the operator will use a Macintosh laryngoscope on the first laryngoscopy attempt.

Wat meet het onderzoek?

Primaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Number of intubations with successful tracheal intubation on the first attempt
Tijdsspanne: Duration of procedure of procedure (minutes)

The primary outcome is successful tracheal intubation on the first attempt, defined as placement of an endotracheal tube in the trachea following a single insertion of the laryngoscope blade into the mouth, without its removal.

Duration of procedure of procedure (minutes)

Secundaire uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Successful intubation
Tijdsspanne: Duration of procedure (minutes)

Successful placement of a tube in the trachea

Duration of procedure (minutes)
Incidence of "easy intubation"
Tijdsspanne: Duration of procedure (minutes)

Easy intubation is defined as a patient with modified Cormack-Lehane I-IIa glottic view and intubation on the first attempt.

Duration of procedure (minutes)
Number of laryngoscopy attempts
Tijdsspanne: Duration of procedure (minutes)

Number of laryngoscopy attempts

Duration of procedure (minutes)
Number of attempts to cannulate the trachea with a bougie or an endotracheal tube
Tijdsspanne: Duration of procedure (minutes)

Number of attempts to cannulate the trachea with a bougie or an endotracheal tube

Duration of procedure (minutes)
Duration of tracheal intubation
Tijdsspanne: Duration of procedure (minutes)

The interval (in seconds) between the first insertion of a laryngoscope blade into the mouth and the final placement of an endotracheal tube in the trachea.

Duration of procedure (minutes)
Reason for failure to intubate on the first attempt
Tijdsspanne: Duration of procedure (minutes)

Reason for failure among those who did not meet the primary outcome (successful intubation on the first attempt):

  1. Inadequate view of the larynx
  2. Inability to intubate the trachea with an endotracheal tube
  3. Inability to cannulate the trachea with a bougie
  4. Attempt aborted due to change in patient condition (e.g., worsening hypoxemia, hypotension, bradycardia, vomiting, bleeding)
  5. Technical failure of the laryngoscope (e.g., battery, light source, camera, screen)
  6. Other
Duration of procedure (minutes)
Operator-assessed difficulty of intubation
Tijdsspanne: Duration of procedure (minutes)

Operator-assessed difficulty of intubation

  1. without difficulty
  2. mild difficulty
  3. moderate difficulty
  4. severe difficulty
Duration of procedure (minutes)
Glottic view assessed using the modified Cormack-Lehane classification
Tijdsspanne: Duration of procedure (minutes)

Modified Cormack-Lehane grade of glottic view:

I: full view of the glottis, IIa: partial view of the glottis, IIb: arytenoid or posterior part of the vocal cords just visible, III: only epiglottis visible, IV: neither glottis nor epiglottis visible Cormack-Lehane grade of glottic view

Duration of procedure (minutes)
Glottic view assessed using the percentage of glottic opening (POGO score).
Tijdsspanne: Duration of procedure (minutes)

The Percentage of Glottic Opening (POGO) score is defined as the percentage (0% to 100%) of the glottic opening visualised during laryngoscopy, from the anterior commissure to the interarytenoid notch. A score of 0% indicates that no glottic structures are visible, whereas 100% indicates full visualisation of the glottis.

Duration of procedure (minutes)
Need for additional airway equipment
Tijdsspanne: Duration of procedure (minutes)

Airway equipment: bougie, stylet, other videolaryngoscope, others.

Duration of procedure (minutes)
Need to change the device for intubation
Tijdsspanne: Duration of procedure (minutes)

Need to replace by another device, a different angled blade, requirement for a fiberoptic bronchoscope...).

Duration of procedure (minutes)

Andere uitkomstmaten

Uitkomstmaat
Maatregel Beschrijving
Tijdsspanne
Complications of tracheal intubation
Tijdsspanne: From induction to 15 minutes following tracheal intubation
  1. Hypoxemia (lowest oxygen saturation measured by pulse oximetry 80%-90%),

  2. Severe hypoxemia (lowest oxygen saturation measured by pulse oximetry < 80%),

  3. Severe bradycardia:

    1. 0-3 months old: HR < 80 bpm,
    2. 4 months - 2 years: HR < 60 bpm,
    3. 2-10 years old: HR < 40 bpm,
    4. 10-16 years old: HR < 30 bpm at least 1 minute,
  4. Laryngospasm,

  5. Bronchospasm,

  6. Obstruction of tracheal tube,

  7. Airway injuries (bleeding,...),

  8. Dental injuries,

  9. Can't intubate, can't oxygenate (CICO) situation,

  10. Severe bradycardia/Cardiac arrest

  11. Pulmonary aspiration

  12. Pneumothorax/ pneumomediastinum

From induction to 15 minutes following tracheal intubation

Medewerkers en onderzoekers

Hier vindt u mensen en organisaties die betrokken zijn bij dit onderzoek.

Onderzoekers

  • Hoofdonderzoeker: Manuel Taboada Muñiz, University Clinical Hospital of Santiago de Compostela

Publicaties en nuttige links

De persoon die verantwoordelijk is voor het invoeren van informatie over het onderzoek stelt deze publicaties vrijwillig ter beschikking. Dit kan gaan over alles wat met het onderzoek te maken heeft.

Studie record data

Deze datums volgen de voortgang van het onderzoeksdossier en de samenvatting van de ingediende resultaten bij ClinicalTrials.gov. Studieverslagen en gerapporteerde resultaten worden beoordeeld door de National Library of Medicine (NLM) om er zeker van te zijn dat ze voldoen aan specifieke kwaliteitscontrolenormen voordat ze op de openbare website worden geplaatst.

Bestudeer belangrijke data

Studie start (Werkelijk)

1 juni 2026

Primaire voltooiing (Geschat)

30 december 2027

Studie voltooiing (Geschat)

30 december 2027

Studieregistratiedata

Eerst ingediend

21 maart 2026

Eerst ingediend dat voldeed aan de QC-criteria

21 maart 2026

Eerst geplaatst (Werkelijk)

27 maart 2026

Updates van studierecords

Laatste update geplaatst (Werkelijk)

21 september 2026

Laatste update ingediend die voldeed aan QC-criteria

17 september 2026

Laatst geverifieerd

1 september 2026

Meer informatie

Termen gerelateerd aan deze studie

Plan Individuele Deelnemersgegevens (IPD)

Bent u van plan om gegevens van individuele deelnemers (IPD) te delen?

NEE

Beschrijving IPD-plan

Individual participant data will not be routinely shared due to regulatory and data protection restrictions across participating countries. Data access may be considered on a case-by-case basis, subject to applicable regulations and approval by the study investigators.

Informatie over medicijnen en apparaten, studiedocumenten

Bestudeert een door de Amerikaanse FDA gereguleerd geneesmiddel

Nee

Bestudeert een door de Amerikaanse FDA gereguleerd apparaatproduct

Nee

Deze informatie is zonder wijzigingen rechtstreeks van de website clinicaltrials.gov gehaald. Als u verzoeken heeft om uw onderzoeksgegevens te wijzigen, te verwijderen of bij te werken, neem dan contact op met register@clinicaltrials.gov. Zodra er een wijziging wordt doorgevoerd op clinicaltrials.gov, wordt deze ook automatisch bijgewerkt op onze website .

Abonneren